Specifically, Ptdss1-deficient tumor cells were more responsive to IFN-γ stimulation through the STAT1 signaling pathway, resulting in greater MHC-I surface expression, and, ultimately, enhanced CD8+ T cell–mediated cell killing in vitro. The gene discussed is CD8A; the disease is neoplasm.